Breaking News Instant updates and real-time market news.

TCRR

TCR2 Therapeutics

$15.01

-0.39 (-2.53%)

16:16
05/13/19
05/13
16:16
05/13/19
16:16

TCR2 Therapeutics reports Q1 EPS ($4.85), may not compare with consensus (47c)

TCR2 ended Q1 with $191.7M in cash, cash equivalents and investments compared to $123.2M as of December 31, 2018.

  • 13

    May

TCRR TCR2 Therapeutics
$15.01

-0.39 (-2.53%)

03/11/19
WEDB
03/11/19
INITIATION
Target $28
WEDB
Outperform
TCR2 Therapeutics initiated with an Outperform at Wedbush
Wedbush analyst David Nierengarten initiated TCR2 Therapeutics with an Outperform rating and $28 price target. In a research note to investors, Nierengarten contends that shares are undervalued based onhis positive outlook on the company's potentially best-in-class CAR-T cell platform, which is developing T-cell receptor Fusion Construct T cells, or TRuC-T cells,for both solid tumor and hematologic malignancies. To date, the platform has generated one clinical and two near-clinicalproduct candidates, including TC-210, currently in Ph 1 for mesothelin-expressing solid tumors, and TC-110 and TC-220, which are both in IND-enabling studies for CD19-positive B-cell malignancies and MUC16-expressing solid tumors.
03/11/19
JEFF
03/11/19
INITIATION
Target $31
JEFF
Buy
Jefferies starts TCR2 Therapeutics with Buy rating, $31 price target
Jefferies analyst Biren Amin initiated coverage of TCR2 Therapeutics with a Buy rating and $31 price target. The company is developing a "broad pipeline" centered on its TRuC technology that endows certain advantageous properties to T-cells for targeting solid tumors, where CAR-Ts have not seen much success, Amin tells investors in a research note. While early in development, the analyst believes TCR2 may offer a differentiated approach.
03/11/19
LEER
03/11/19
INITIATION
Target $27
LEER
Outperform
TCR2 Therapeutics initiated with an Outperform at SVB Leerink
SVB Leerink analyst Jonathan Chang initiated TCR2 Therapeutics with an Outperform rating and $27 price target. In a research note to investors, Chang says he has received positive feedback from MEDACorp Key Opinion Leaders on the company's T-Cell Receptor Fusion Construct pipeline based on the preclinical data to date that highlights the potential of TCR2's approach. The analyst maintains a positive long-term view of the stock based on the experienced management team and potentially transformative platform with broad therapeutic applicability.
03/11/19
03/11/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. TCR2 Therapeutics (TCRR) initiated with an Outperform at SVB Leerink, Wedbush, and BMO Capital, while being initiated with a Buy at Jefferies. 2. Barings BDC (BBDC) resumed with an Outperform at Wells Fargo. 3. Avedro (AVDR) initiated with an Overweight at JPMorgan while being initiated with an Outperform at SVB Leerink and Cowen. 4. Anchiano Therapeutics (ANCN) initiated with a Buy at Ladenburg and an Outperform at Oppenheimer. 5. CytomX Therapeutics (CTMX) initiated with an Overweight at Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

HCAT

Health Catalyst

$42.50

0.96 (2.31%)

06:31
08/19/19
08/19
06:31
08/19/19
06:31
Initiation
Health Catalyst initiated  »

Health Catalyst initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

WLL

Whiting Petroleum

$8.61

0.36 (4.36%)

06:30
08/19/19
08/19
06:30
08/19/19
06:30
Downgrade
Whiting Petroleum rating change  »

Whiting Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 08

    Oct

  • 09

    Oct

ARCC

Ares Capital

$18.63

0.27 (1.47%)

06:29
08/19/19
08/19
06:29
08/19/19
06:29
Upgrade
Ares Capital rating change  »

Ares Capital upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTVA

Corteva

$30.25

1.84 (6.48%)

06:26
08/19/19
08/19
06:26
08/19/19
06:26
Upgrade
Corteva rating change  »

Corteva upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$183.42

0.78 (0.43%)

, ACN

Accenture

$193.19

3.675 (1.94%)

06:25
08/19/19
08/19
06:25
08/19/19
06:25
Periodicals
Facebook content moderation firm sought counseling details, The Intercept says »

A Facebook (FB) content…

FB

Facebook

$183.42

0.78 (0.43%)

ACN

Accenture

$193.19

3.675 (1.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 24

    Sep

  • 26

    Sep

  • 27

    Oct

PROS

ProSight

$18.71

-0.5 (-2.60%)

06:23
08/19/19
08/19
06:23
08/19/19
06:23
Initiation
ProSight initiated  »

ProSight initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$206.44

4.71 (2.33%)

06:23
08/19/19
08/19
06:23
08/19/19
06:23
Periodicals
Apple CEO Cook has met Trump 'at least' 5 times in a year, BI reports »

Apple CEO Tim Cook has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POL

PolyOne

$31.01

0.73 (2.41%)

06:21
08/19/19
08/19
06:21
08/19/19
06:21
Earnings
PolyOne raises FY19 adj. EPS view to up 6%-8% from up 4%-6%, consensus $2.54 »

Guidance reflects the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

AMZN

Amazon.com

$1,791.82

16.72 (0.94%)

06:20
08/19/19
08/19
06:20
08/19/19
06:20
Periodicals
Amazon beats IRS appeal in U.S. tax dispute, Reuters reports »

Amazon on Friday defeated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

ARMK

Aramark

$37.07

-0.07 (-0.19%)

06:19
08/19/19
08/19
06:19
08/19/19
06:19
Upgrade
Aramark rating change  »

Aramark upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$203.95

4.74 (2.38%)

06:19
08/19/19
08/19
06:19
08/19/19
06:19
Downgrade
Amgen rating change  »

Amgen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 16

    Sep

  • 19

    Sep

POL

PolyOne

$31.01

0.73 (2.41%)

06:18
08/19/19
08/19
06:18
08/19/19
06:18
Hot Stocks
PolyOne to sell PP&S business to SK Capital Partners for $775M in cash »

PolyOne announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

CNHI

CNH Industrial

$8.82

0.18 (2.08%)

06:18
08/19/19
08/19
06:18
08/19/19
06:18
Upgrade
CNH Industrial rating change  »

CNH Industrial upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENLC

EnLink Midstream

$7.74

0.19 (2.52%)

06:17
08/19/19
08/19
06:17
08/19/19
06:17
Downgrade
EnLink Midstream rating change  »

EnLink Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 06

    Nov

HEP

Holly Energy Partners

$27.48

0.31 (1.14%)

06:17
08/19/19
08/19
06:17
08/19/19
06:17
Downgrade
Holly Energy Partners rating change  »

Holly Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$89.46

0.91 (1.03%)

06:17
08/19/19
08/19
06:17
08/19/19
06:17
Periodicals
Novartis to respond to demand for data manipulation details, Reuters says »

Novartis plans to answer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

GOOG

Alphabet

$1,176.94

9.48 (0.81%)

, GOOGL

Alphabet Class A

$1,178.69

9.68 (0.83%)

06:15
08/19/19
08/19
06:15
08/19/19
06:15
Periodicals
Google cuts some Android phone data for wireless carriers, Reuters reports »

Google has shut down its…

GOOG

Alphabet

$1,176.94

9.48 (0.81%)

GOOGL

Alphabet Class A

$1,178.69

9.68 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Oct

EWBC

East West Bancorp

$39.90

1.52 (3.96%)

06:15
08/19/19
08/19
06:15
08/19/19
06:15
Downgrade
East West Bancorp rating change  »

East West Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARMK

Aramark

$37.07

-0.07 (-0.19%)

06:14
08/19/19
08/19
06:14
08/19/19
06:14
Upgrade
Aramark rating change  »

Aramark upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SONO

Sonos

$11.90

0.22 (1.88%)

06:13
08/19/19
08/19
06:13
08/19/19
06:13
Upgrade
Sonos rating change  »

Sonos upgraded to Strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VWAGY

Volkswagen

$0.00

(0.00%)

06:13
08/19/19
08/19
06:13
08/19/19
06:13
Periodicals
Volkswagen, SEC ordered to seek settlement on fraud allegations, WSJ reports »

Volkswagen and the SEC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLL

Whiting Petroleum

$8.61

0.36 (4.36%)

06:12
08/19/19
08/19
06:12
08/19/19
06:12
Downgrade
Whiting Petroleum rating change  »

Whiting Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 08

    Oct

  • 09

    Oct

APD

Air Products

$228.77

2.32 (1.02%)

06:12
08/19/19
08/19
06:12
08/19/19
06:12
Downgrade
Air Products rating change  »

Air Products downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

EADSY

Airbus

$0.00

(0.00%)

06:11
08/19/19
08/19
06:11
08/19/19
06:11
Periodicals
Airbus using AI to save millions on finance tasks, WSj reports »

Airbus is using…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Sep

CSTL

Castle Biosciences

$20.14

-0.56 (-2.71%)

06:10
08/19/19
08/19
06:10
08/19/19
06:10
Initiation
Castle Biosciences initiated  »

Castle Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.